Kenya's Drug Control Policy: What Harm Reduction Advocates Need to Know

Kenya's approach to drug and alcohol control is shaped by a complex web of legislation, national policies, and international treaty obligations. For harm reduction advocates — whether working in communities, healthcare, or policy — understanding this framework is essential to knowing what is currently possible, what barriers exist, and where the opportunities for change lie.

The Core Legislative Framework

Kenya's drug control is primarily governed by three instruments:

The Narcotic Drugs and Psychotropic Substances (Control) Act (1994)

This is Kenya's principal drug law. It criminalises the possession, use, trafficking, and supply of controlled substances including cannabis, heroin, cocaine, and methamphetamine. Penalties range from fines to lengthy prison sentences. The law reflects a predominantly punitive, law-enforcement-centred approach to drug control that was dominant globally in the 1980s–90s.

The Alcoholic Drinks Control Act (2010)

This Act governs the production, sale, and consumption of alcohol in Kenya. Key provisions include licensing requirements, restrictions on operating hours, age limits (18+), and prohibitions on certain marketing practices. Enforcement has been inconsistent, particularly for illicit alcohol producers.

The National Authority for the Campaign Against Alcohol and Drug Abuse (NACADA)

Established under the NACADA Act (2012), NACADA is the principal government body for coordinating Kenya's response to alcohol and drug abuse. It has a mandate that includes prevention, treatment, research, and policy advocacy. NACADA has increasingly engaged with harm reduction concepts, though tension with punitive approaches remains.

The National Policy on Prevention, Management and Control of Alcohol, Drug and Substance Abuse

Kenya's National Drug Policy provides the strategic framework guiding government action on substance use. Key elements include:

• Prevention: Emphasis on demand reduction through education, community mobilisation, and early intervention.
• Treatment and Rehabilitation: Recognition that substance use disorders require health-based responses, not only criminal justice responses.
• Supply Reduction: Law enforcement action against drug trafficking and illicit production.
• International Cooperation: Alignment with Kenya's obligations under the UN drug control conventions.

Critically, the policy lacks explicit recognition of harm reduction as a core pillar — a significant gap compared to international best-practice frameworks that include harm reduction alongside prevention, treatment, and supply reduction.

What Kenya's Policy Gets Right

Kenya's policy landscape is not entirely hostile to harm reduction. Several positive developments are worth noting:

• The Ministry of Health has supported needle and syringe programmes in several counties, recognising their role in preventing HIV transmission among people who inject drugs.
• NACADA has acknowledged the evidence base for harm reduction in several of its research publications.
• Methadone maintenance treatment (MMT) — a key harm reduction tool for opioid dependence — is available at several public health facilities in Nairobi, Mombasa, and Kilifi.
• County governments in Mombasa and Nairobi have piloted community-based harm reduction programmes targeting people who use drugs.

Where Kenya's Policy Falls Short

Despite these positive steps, significant gaps remain:

• Criminalisation of people who use drugs: Possession of even small quantities of controlled substances remains a criminal offence, which drives drug use underground, increases risks, and deters people from accessing health services.
• No formal harm reduction policy: Unlike countries such as Portugal, Switzerland, or even neighbouring Tanzania (which has formal NSP policy), Kenya lacks a national harm reduction strategy that sets out clear service standards and funding commitments.
• Limited treatment access: Public drug treatment services are concentrated in urban areas. Rural and peri-urban communities — where drug use is growing rapidly — have virtually no access to treatment.
• Illicit alcohol regulation: Despite the Alcoholic Drinks Control Act, illicit alcohol production and sale remains widespread and largely uncontrolled, creating serious public health risks.
• Stigma in healthcare settings: People who use drugs routinely report discrimination and mistreatment by healthcare workers, deterring them from seeking care.

What Harm Reduction Advocates Are Calling For

HRSK and other harm reduction organisations in Kenya are advocating for:

• A formal National Harm Reduction Strategy that recognises harm reduction as a health-based approach distinct from — but complementary to — prevention and treatment.
• Decriminalisation of drug possession for personal use, redirecting resources from the criminal justice system to the health system.
• Scale-up of evidence-based services: expanded methadone maintenance treatment, needle and syringe programmes, naloxone distribution, and drug checking services.
• Integration of harm reduction into the primary healthcare system so that services reach people outside major cities.
• Community engagement: ensuring that people with lived experience of drug use are meaningfully included in policy design and service delivery.

The International Context

Kenya is a signatory to the three UN drug control conventions (1961, 1971, 1988). For many years, these treaties were interpreted as requiring criminalisation of drug use. However, UN treaty bodies — including the WHO, UNAIDS, UNDP, and OHCHR — have issued joint statements affirming that harm reduction is fully consistent with treaty obligations, and that drug policy should prioritise health and human rights.

The global trend is moving toward health-centred, rights-based drug policy. Kenya has an opportunity to lead in the East African region — as it has in other areas of public health — by embracing evidence-based harm reduction.

How You Can Engage

Advocacy for better drug policy is not only for policy professionals. Community members, healthcare workers, journalists, and people with lived experience all have a role to play:

• Share evidence on harm reduction effectiveness with local officials and community leaders.
• Support organisations like HRSK that are working to shift the policy landscape.
• Engage with county government processes — county health departments have significant discretion in how national policy is implemented locally.
• Share your own story, if you are comfortable doing so. Lived experience is one of the most powerful forces in changing policy.